BALAJI AMINES

Balaji Amines closed FY26 with a strong fourth quarter — EBITDA margins of 25%, a sequential ramp in specialty chemicals volumes, and management guidance of 10–15% volume growth for FY27 with margins of 22–23%. The stated growth agenda rests on the 100,000-TPA DME plant (reported as fully committed), electronic-grade DMC and DMF, an improved-process acetonitrile plant, NMM, and a ₹750 crore expansion at Balaji Speciality Chemicals centred on EDA derivatives, HCN and EDTA. The backdrop is supportive: global amine supply remains tight on West Asia disruption, and prices have firmed.